p21 produces a bioactive secretome that places stressed cells under immunosurveillance
How can you avoid taking too much Ozempic
Using them together could create an additive glucose-lowering effect
Blood Sugar Drops and Cardiovascular Stability Non-diabetic users taking semaglutide rarely experience dangerous hypoglycemia because the drug's mechanism includes a glucose-dependent insulin responseinsulin release slows when glucose is already low
Compounded semaglutide can be stored in the fridge for up to 120 days if kept at the right temperature
Injectable GLP-1s: Nearly 100% bioavailability Consistent, predictable absorption Doses of 1-2.4mg weekly for semaglutide FDA-Approved Oral Tablets: 0.4-1% bioavailability Requires 7-25mg doses to achieve similar effects Must be taken with specific timing and fasting requirements Compounded ODT Formulations: Theoretical bioavailability advantage over swallowed tablets Sublingual/buccal delivery bypasses stomach acid and first-pass metabolism However, research on peptide delivery shows challenges: peptides may be degraded by salivary enzymes, have poor permeability due to large molecular size, and face continuous wash-away from saliva No clinical trials have established actual bioavailability or effectiveness for compounded GLP-1 ODTs These formulations are not FDA-approved and haven't undergone rigorous testing The theoretical advantage of ODT formulations is that by dissolving in the mouth rather than the stomach, they could achieve better absorption than swallowed tablets while maintaining the convenience of a daily, needle-free option
